95%(SDS-PAGE),EC50=3.8ng/mL(ELISA,immobilized CD30L),低内毒素,高稳定性。CD30为TNF受体超家族成员,在霍奇金淋巴瘤(HD)、间变性大细胞淋巴瘤(ALCL)及部分非霍奇金淋巴瘤中高表达,是研究血液恶性肿瘤机制、CAR-T靶点开发及ELISA标准品制备的理想试剂。" data-qmeta="description">
Recombinant Human CD30/TNFRSF8 Protein, hFc Tag
产品详情
FAQ
产品文档
已发表文献
产品介绍

The transmembrane receptor CD30 (TNFRSF8) and its ligand CD30L (CD153, TNFSF8) are members of the tumor necrosis factor (TNF) superfamily and display restricted expression in subpopulations of activated T-and B-cells in nonpathologic conditions. CD30 expression is upregulated in various hematological malignancies, including Reed-Sternberg cells in Hodgkin's disease (HD), anaplastic large cell lymphoma (ALCL) and subsets of Non-Hodgkin's lymphomas (NHLs).

产品性质
产品特色

高活性、高纯度、低内毒素、高稳定性

应用案例


                 SDS-PAGE

               

  Human CD30 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


                 ELISA Data


Immobilized Human CD30 Ligand, His Tag at 5μg/ml (100μl/well) on the plate. Dose response curve for Human CD30, hFc Tag with the EC50 of 3.8ng/ml determined by ELISA.

存储条件

-25 ~ -15℃保存,收到货之后有效期1年。复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。

COA
已发表文献
联系我们
购物车
客服
转染试用